Evidence map›Paper›PMID 24732107›Full record

ArticlePediatric research2014

Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups.

Milenka Cuevas Guaman, Elena Sbrana, Cynthia Shope, Lori Showalter, Min Hu, Sylvain Meloche, Kjersti Aagaard

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. A Genome-Wide Association Study in Early COPD: Identification of One Major Susceptibility Loci.International journal of chronic obstructive pulmonary disease · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Milenka Cuevas GuamanDivision of Neonatology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
Elena SbranaDepartment of Pathology, University of Texas Medical Branch-Galveston, Galveston, Texas.
Cynthia ShopeDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Lori ShowalterDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Min HuDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Sylvain MelocheInstitut de Recherche en Immunologie et Cancérologie, Université de Montreal, Montréal, Québec, Canada.
Kjersti Aagaard1] Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas [2] Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas.
Baylor College of Medicine · USInstitute for Research in Immunology and Cancer · CAThe University of Texas Medical Branch at Galveston · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Conserved Fetal Epigenomic Signatures in a Primate Model of Maternal ObesityR01DK089201 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2012 to 2021
$5.1M
Characterization of the Fetal Primate Epigenome and Metabolome Under In UteroDP2OD001500 · OD · BAYLOR COLLEGE OF MEDICINE · PI AAGAARD, KJERSTI MARIE · 2007 to 2011
$2.3M
NICHD NIH HHS L40 HD051105NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK089201NIH HHS DP2 OD001500
6 · The paper itself

Abstract

backgroundRespiratory distress syndrome (RDS) persists as a prevalent cause of infant morbidity and mortality. We have previously demonstrated that deletion of Erk3 results in pulmonary immaturity and neonatal lethality. Using RNA sequencing, we identified corticotrophin releasing hormone (CRH) and surfactant protein B (SFTPB) as potential molecular mediators of Erk3-dependent lung maturation. In this study, we characterized the impact of antenatal glucocorticoids and postnatal surfactant on neonatal survival of Erk3 null mice.

methodsIn a double crossover design, we administered dexamethasone (dex) or saline to pregnant dams during the saccular stage of lung development, followed by postnatal surfactant or saline via inhalation intubation. Survival was recorded, and detailed lung histological analysis and staining for CRH and SFTPB protein expression were performed.

resultsWithout treatment, Erk3 null pups die within 6 h of birth with reduced aerated space, impaired thinning of the alveolar septa, and abundant glycogen stores, as described in human RDS. The administration of dex and surfactant improved RDS-associated lethality of Erk3(-/-) pups and partially restored functional fetal lung maturation by accelerating the downregulation of pulmonary CRH and partially rescuing the production of SFTPB.

conclusionThese findings emphasize that Erk3 is integral to terminal differentiation of type II cells, SFTPB production, and fetal pulmonary maturity.

Indexed as

AnimalsCell DifferentiationCorticotropin-Releasing HormoneCross-Over StudiesDexamethasoneDisease Models, AnimalFemaleGlucocorticoidsLungMaleMaternal ExposureMiceMice, Inbred C57BLMice, KnockoutMitogen-Activated Protein Kinase 6PregnancyCorticotropin-Releasing HormoneDexamethasoneGlucocorticoidsMapk6 protein, mouseMitogen-Activated Protein Kinase 6Pulmonary Surfactant-Associated Protein BPulmonary Surfactants

Identifiers

PMID24732107
PMCPMC4062596
OpenAlexW2008276104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.